PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
29-Mar-2024 CD Genomics Unveils Revolution in Genomic Research with ddRAD-seq Service CD Genomics
28-Mar-2024 Data from Brainomix's Collaboration with AstraZeneca Shows its AI-Powered e-Lung Better Identifies Lung Fibrosis Patients at Risk of Decline Brainomix
28-Mar-2024 Corteria Pharmaceuticals announces initiation of Phase 1 study to evaluate CRF2 agonist COR-1167 for treatment of worsening heart failure Corteria Pharmaceuticals
27-Mar-2024 Integrated DNA Technologies Unveils New Custom Vector Onboarding Tool to Optimize Gene Synthesis Integrated DNA Technologies
27-Mar-2024 Top Eight Reasons to Attend Semantic Data 2024:  Taxonomy, Ontology, and Knowledge Graphs Conference  Henry Stewart
27-Mar-2024 11th Edition Human Factors and User Experience for Medical Device Design Conference Set to Equip Industry Leaders with Innovative Strategies marcus evans
27-Mar-2024 AstraZeneca CEO Sir Pascal Soriot Awarded Top Science Honour AstraZeneca
27-Mar-2024 Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa Vector Pharma FZCO
27-Mar-2024 Creative Enzymes Amplifies Biochemical Research with the Launch of Native Roxburgh Superoxide Dismutase Creative Enzymes
27-Mar-2024 Creative Enzymes Rolls Out Recombinant Aprotinin from Bovine for Redefining Proteinase Inhibition Creative Enzymes
27-Mar-2024 Profacgen Updated Its Protein Co-Expression Service in Mammalian Cells Profacgen
27-Mar-2024 Creative BioMart Provides a Comprehensive List of ALB Proteins for Research Use Creative BioMart
26-Mar-2024 Panthera Biopartners appoints Martyn Jellett as Associate Director Business Development to support growing commercial team Panthera Biopartners
26-Mar-2024 Asceneuron Joins Critical Path for Alzheimer’s Disease Consortium Asceneuron
26-Mar-2024 Research published in Journal of the American Chemical Society highlights potential of HIF Inhibition as a therapeutic approach for cancers Curve Therapeutics
26-Mar-2024 STORM Therapeutics to Present Data on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at AACR Annual Meeting 2024 STORM Therapeutics Ltd
26-Mar-2024 Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team Laverock Therapeutics
26-Mar-2024 Endostart receives FDA 510(k) clearance for Endorail®, ushering in new era of gastrointestinal endoscopy innovation Andrew Lloyd Associates
26-Mar-2024 PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition PharmaBlock
26-Mar-2024 Corteria Pharmaceuticals announces initiation of Phase 1 study to evaluate CRF2 agonist COR-1167 for treatment of worsening heart failure Andrew Lloyd Associates